Copper availability and accumulation by Portulaca oleracea Linn. stem cutting.

Environ Monit Assess

Department of Environmental Sciences, Bharathiar University, Coimbatore, 641 046, India.

Published: May 2006

The Cu accumulation capacity of stem cuttings of Portulaca oleracea was assessed in two different soils, alfisol and vertisol, which differ from each other mainly due to their clay content - several fold lower in the former than in the latter. The DTPA extractable concentration of Cu in soil and the level of its accumulation in stem cuttings were, therefore, greater in alfisol than in vertisol. In the mixed soils, the DTPA extractable as well as plant accumulated levels of Cu decreased with an increase in the proportion of vertisol. With an increase in the soil available and plant accumulated Cu, a decrease has been observed in the ability of stem cuttings to regenerate leaves and roots. As a consequence biomass reduction has been observed with an increase in the concentration of Cu in the soil and plant body. In view of comparatively low availability of Cu in vertisol, regeneration of stem cuttings occurred up to a concentration of 1600 microg of Cu/g of soil, whereas in alfisol it occurred only up to 200 microg of Cu/g of soil. The results of the present study showed that P. oleracea stem cutting is an accumulator of Cu and the availability of Cu in soils could be manipulated through addition of clay since the plant available concentration of Cu is less in the soil (vertisol) with high clay content.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10661-006-7235-zDOI Listing

Publication Analysis

Top Keywords

stem cuttings
16
concentration soil
12
portulaca oleracea
8
stem cutting
8
alfisol vertisol
8
clay content
8
dtpa extractable
8
plant accumulated
8
soil plant
8
microg cu/g
8

Similar Publications

Dual-double stem cell therapy, which integrates mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs), represents a cutting-edge approach in regenerative medicine, particularly for conditions such as ovarian decline, premature ovarian insufficiency (POI), and induced ovarian failure. This therapy leverages the unique properties of MSCs and HSCs, enhancing tissue repair, immune modulation, and overall regenerative outcomes. MSCs, known for their ability to differentiate into various cell types, provide a supportive microenvironment and secrete bioactive molecules that promote angiogenesis and reduce inflammation.

View Article and Find Full Text PDF

The Ralstonia solanacearum Species Complex (RSSC) is the most significant plant pathogen group with a wide host range. It is genetically related but displays distinct biological features, such as restrictive geography occurrence. The RSSC comprises three species: Ralstonia pseudosolanacearum (phylotype I and III), Ralstonia solanacearum (phylotype IIA and IIB), and Ralstonia syzygii (phylotype IV) (Fegan and Prior 2005).

View Article and Find Full Text PDF

Microneedles (MNs) appear as a transformative and minimally invasive platform for transdermal drug delivery, representing a highly promising strategy in wound healing therapeutics. This technology, entailing the fabrication of micron-scale needle arrays, enables the targeted and efficient delivery of bioactive agents into the epidermal and dermal layers without inducing significant pain or discomfort. The precise penetration of MNs facilitates localized and sustained drug release, which significantly enhances tissue regeneration and accelerates wound closure.

View Article and Find Full Text PDF

Smart Cell Therapy: an industry perspective on macrophages as living drugs.

Cytotherapy

December 2024

Barcia Novel Therapies, Lexington, Massachusetts, USA. Electronic address:

Macrophage-based cell therapies represent a cutting-edge frontier in immunotherapy, offering distinct advantages over conventional approaches like CAR-T. This review explores the potential of macrophages to orchestrate both innate and adaptive immune responses, enhancing the body's ability to combat diseases locally and systemically. Dubbed a "Smart Cell Therapy," macrophages can initiate and coordinate complex immunological cascades, leveraging multiple immune system components while also performing effector functions.

View Article and Find Full Text PDF

Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials.

Stem Cell Res Ther

January 2025

School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, 10F., Teaching & Research Building, Shuang-Ho Campus, No. 301, Yuantong Rd., Zhonghe Dist., Taipei, 235, Taiwan.

Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, and regenerative capabilities, along with the ability to transdifferentiate into hepatocytes. This review delves into the latest advances in MSC-based treatments for chronic and end-stage liver diseases, as highlighted in current clinical trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!